Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation
Clinical trial NCT05039359 · TERMINATED
Trial details
- NCT number
- NCT05039359
- Sponsor
- InCarda Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-26
- Primary completion
- 2023-05-22
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.